Spots Global Cancer Trial Database for Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
Official Title: Role of Ablative Radiotherapy in the Management of Metastatic Disease: A Patient Data Registry
Study ID: NCT04085029
Interventions
Study Description
Brief Summary: The purpose of this study is to provide a registry of participants in order to assess the acute adverse event rates following ablative radiotherapy for metastatic disease.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Duke Cancer Institute Cary, Cary, North Carolina, United States
Durham Veterans Administration Health Care System (DVAHCS), Durham, North Carolina, United States
Duke University Medical Center, Durham, North Carolina, United States
Duke Women's Cancer Care Raleigh, Raleigh, North Carolina, United States
Duke Raleigh Hospital, Raleigh, North Carolina, United States
Contact Details
Name: Joseph Salama, MD
Affiliation: Duke University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
